Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Diabetes is one of the most common chronic diseases and a leading cause of morbidity and mortality in the U.S. Although our ability to treat diabetes and its associated complications has significantly improved, presentation with uncontrolled diabetes leading to ketoacidosis remains a significant problem. RESEARCH DESIGN AND METHODS: We aimed to determine the incidence and costs of hospital admissions associated with diabetic ketoacidosis (DKA). We reviewed the National Inpatient Sample database for all hospitalizations in which DKA (ICD-9 codes 250.10, 250.11, 250.12, and 250.13) was the principal discharge diagnosis during 2003–2014 and calculated the population incidence by using U.S. census data. Patients with ICD-9 codes for diabetic coma were excluded because the codes do not distinguish between hypoglycemic and DKA-related coma. We then analyzed changes in temporal trends of incidence, length of stay, costs, and in-hospital mortality by using the Cochrane-Armitage test. RESULTS: There were 1,760,101 primary admissions for DKA during the study period. In-hospital mortality for the cohort was 0.4% (n = 7,031). The total number of hospital discharges with the principal diagnosis of DKA increased from 118,808 in 2003 to 188,965 in 2014 (P < 0.0001). The length of stay significantly decreased from an average of 3.64 days in 2003 to 3.24 days in 2014 (P < 0.01). During this period, the mean hospital charges increased significantly from $18,987 (after adjusting for inflation) per admission in 2003 to $26,566 per admission in 2014. The resulting aggregate charges (i.e., national bill) for diabetes with ketoacidosis increased dramatically from $2.2 billion (after adjusting for inflation) in 2003 to $ 5.1 billion in 2014 (P < 0.001). However, there was a significant reduction in mortality from 611 (0.51%) in 2003 to 620 (0.3%) in 2014 (P < 0.01). CONCLUSIONS: Our analysis shows that the population incidence for DKA hospitalizations in the U.S. continues to increase, but the mortality from this condition has significantly decreased, indicating advances in early diagnosis and better inpatient care. Despite decreases in the length of stay, the costs of hospitalizations have increased significantly, indicating opportunities for value-based care intervention in this vulnerable population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both DKA and HHS impart a substantial risk of subsequent morbidity and mortality and high associated health care costs (165).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [165]
In the citing paper
“While DKA mortality decreased in the first decade of the 21st century (166)”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [166]
In the citing paper
“DKA and the hyperglycemic hyperosmolar state (HHS) are serious, acute, and lifethreatening hyperglycemic emergencies in individuals with diabetes (165) that incur substantial morbidity, mortality, and costs (166).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [166]
In the citing paper
“Most recently available data for inpatient mortality during hospital admission for DKA ranges from 0.2% in type 1 diabetes (174) to 1.0% in type 2 diabetes (166,175).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [166]
Citations
Cites
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Management of Hyperglycemic Crises in Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., Barrett, E. J., Kreisberg, R. A., Malone, J. I., & Wall, B. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.131 · Cited by 710
Geographic Distribution of Diagnosed Diabetes in the U.S.
Barker, L. E., Kirtland, K. A., Gregg, E. W., Geiss, L. S., & Thompson, T. J. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.12.019 · Cited by 319
The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management
Nyenwe, E. A., & Kitabchi, A. E. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.007 · Cited by 309
Narrative Review: Ketosis-Prone Type 2 Diabetes Mellitus
Umpierrez, G. E., Smiley, D., & Kitabchi, A. E. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00011 · Cited by 299
Insulin Omission in Women With IDDM
Polonsky, W. H., Anderson, B. J., Lohrer, P. A., Aponte, J. E., Jacobson, A. M., & Cole, C. F. (1994) · Diabetes Care · doi:10.2337/diacare.17.10.1178 · Cited by 299
Rewers, A., Klingensmith, G., Davis, C., Petitti, D. B., Pihoker, C., Rodriguez, B., Schwartz, I. D., Imperatore, G., Williams, D., Dolan, L. M., et al. (2008) · Pediatrics · doi:10.1542/peds.2007-1105 · Cited by 298
Kitabchi, A. E., & Nyenwe, E. A. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.09.006 · Cited by 206
Diabetic Ketoacidosis Among Obese African-American Adolescents With NIDDM
Pinhas-Hamiel, O., Dolan, L. M., & Zeitler, P. S. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.484 · Cited by 159
Diabetes in Hispanic American Youth
Lawrence, J. M., Mayer-Davis, E. J., Reynolds, K., Beyer, J., Pettitt, D. J., D'Agostino, R. B., Marcovina, S. M., Imperatore, G., Hamman, R. F., & for the SEARCH for Diabetes in Youth Study Group (2009) · Diabetes Care · doi:10.2337/dc09-s204 · Cited by 150
Klingensmith, G. J., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., Haro, H., Wood, J. R., Lee, J. M., Willi, S. M., Cengiz, E., et al. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12281 · Cited by 140
Type 1 and Type 2 Diabetes in Asian and Pacific Islander U.S. Youth
Liu, L. L., Yi, J. P., Beyer, J., Mayer-Davis, E. J., Dolan, L. M., Dabelea, D. M., Lawrence, J. M., Rodriguez, B. L., Marcovina, S. M., Waitzfelder, B. E., et al. (2009) · Diabetes Care · doi:10.2337/dc09-s205 · Cited by 130
Economic Impact of Diabetic Ketoacidosis in a Multiethnic Indigent Population
Maldonado, M. R., Chong, E., Oehl, M. A., & Balasubramanyam, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1265 · Cited by 126
Chang, D., & Shapiro, M. F. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.4298 · Cited by 119
Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes
Ellis, D. A., Naar‐King, S., Templin, T., Frey, M. A., Cunningham, P. B., Sheidow, A. J., Çakan, N., & Carcone, A. I. (2008) · Diabetes Care · doi:10.2337/dc07-2094 · Cited by 117
Update on diagnosis, pathogenesis and management of ketosis-prone Type 2 diabetes mellitus
Smiley, D. D., Chandra, P., & Umpierrez, G. E. (2011) · Diabetes Management · doi:10.2217/dmt.11.57 · Cited by 86
Presentation and course of Type 2 diabetes in youth in a large multi‐ethnic city
Zdravković, V., Daneman, D., & Hamilton, J. K. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01297.x · Cited by 76
Barriers to Improving Diabetes Care for Blacks
Anderson, R. M., Herman, W. H., Davis, J. M., Freedman, R. P., Funnell, M. M., & Neighbors, H. W. (1991) · Diabetes Care · doi:10.2337/diacare.14.7.605 · Cited by 75
Floyd, B., Chandra, P., Hall, S., Phillips, C., Alema-Mensah, E., Strayhorn, G., Ofili, E. O., & Umpierrez, G. E. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600513 · Cited by 70
Brugel, L., Laurent, M., Caillet, P., Radenne, A., Durand‐Zaleski, I., Martin, M., Baron, M., Kermadec, H. D., Bastuji‐Garin, S., Canouï‐Poitrine, F., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-427 · Cited by 68
Parkin, C. G., Graham, C., & Smolskis, J. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817693253 · Cited by 58
Recreational drug abuse in patients hospitalized for diabetic ketosis or diabetic ketoacidosis
Isidro, M. L., & Jorge, S. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0243-z · Cited by 45
Diabetic ketoacidosis: a complication of type 2 diabetes in Canadian aboriginal youth.
Sellers, E. A., & Dean, H. J. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1202 · Cited by 40
New Long-Acting Basal Insulins: Does Benefit Outweigh Cost?
Standl, E., & Owen, D. R. (2016) · Diabetes Care · doi:10.2337/dcs15-3011 · Cited by 35
Medicaid Families Under Managed Care
Temkin‐Greener, H. (1986) · Medical Care · doi:10.1097/00005650-198608000-00007 · Cited by 27
Cohn, B. G., Keim, S. M., Watkins, J. W., & Camargo, C. A. (2015) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2015.05.016 · Cited by 20
Latent autoimmune diabetes of adulthood
Nabhan, F. A., Emanuele, M. A., & Emanuele, N. (2005) · Postgraduate Medicine · doi:10.3810/pgm.2005.03.1597 · Cited by 15
Experiences of People with Diabetes by Payer Type: An Analysis of the Roper Diabetes Data Set
Garfield, S. S., Xenakis, J. J., Bastian, A., & McBride, M. (2015) · Diabetes Therapy · doi:10.1007/s13300-015-0109-z · Cited by 13
Diabetic Ketoacidosis as First Presentation of Latent Autoimmune Diabetes in Adult
Nadhem, O. N., Nakhla, E., & Smalligan, R. D. (2015) · Case Reports in Medicine · doi:10.1155/2015/821397 · Cited by 12
Will Biosimilar Insulins Be Cheaper?
Heinemann, L., & Carter, A. W. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0294 · Cited by 4
The travesty of expensive insulin
Hawkes, N. (2016) · BMJ · doi:10.1136/bmj.i2933 · Cited by 1
Cited by
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Hyperglycemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0032 · Cited by 278
“In the U.S., the mean length of stay for patients hospitalized with DKA is 3.0 days among people with T1D and 3.7 days among people with T2D (32) and has been shortening over time (29).”
BackgroundInfluentialDhatariya, K. K., & Care, T. J. B. D. S. F. I. (2022) · Diabetic Medicine · doi:10.1111/dme.14788 · Cited by 186
Hyperglycaemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06183-8 · Cited by 225
Metadata
- Authors
- Desai, D., Mehta, D., Mathias, P., Menon, G., & Schubart, U. K.
- Affiliations
- Albert Einstein College of Medicine (US)
- Westchester Medical Center (US)
- Harvard University (US)
- Corresponding author
- Desai, Dimpi
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-05-17
- Volume
- 41
- Issue
- 8
- Pages
- 1631-1638
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2803462035
- Cited by
- 206
- References
- 31
- Citations by year
- 2026: 12 · 2025: 33 · 2024: 30 · 2023: 28 · 2022: 26 · 2021: 34 · 2020: 18 · 2019: 21 · 2018: 3
- FWCI
- 15.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Touro Scholar (Touro College) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetic ketoacidosis, hospitalization incidence, hospital costs, length of hospital stay, in-hospital mortality, temporal trends, uncontrolled diabetes, health care utilization, hospital charges, diabetes complications, National Inpatient Sample, ICD-9-CM codes, health care costs, health policy implications
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Hospitalization, Humans, Infant, Infant, Newborn, Length of Stay, Male, Middle Aged, Patient Acceptance of Health Care, United States, Cohort Studies, Incidence, Databases, Factual, Diabetic Ketoacidosis, Health Care Costs, Hospital Mortality, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.